Acute Kidney Injury

Acute kidney injury (AKI) is a sudden and abrupt loss of renal function leading to the accumulation of toxic waste products in the blood. It is a common complication of severe COVID-19 cases and is associated with increased morbidity and mortality. It occurs due to various causes including hypovolemia, infections, medications, and nephrotoxic agents. AKI is diagnosed through changes in serum creatinine and urine output. The severity of AKI is classified based on the RIFLE or AKIN criteria. Management of AKI involves identifying and treating the underlying cause, optimizing hemodynamic status, and providing renal replacement therapy if needed. Prevention of AKI is key and involves maintaining adequate hydration, avoiding nephrotoxic agents, and minimizing exposure to infections. Management of patients with COVID-19-associated AKI requires careful monitoring of volume status, use of medications with caution, and collaboration between nephrologists and intensivists to optimize care. In conclusion, Acute kidney injury is a serious complication of COVID-19 that can lead to significant morbidity and mortality. It requires early recognition and appropriate management to improve clinical outcomes. Therefore, raising awareness about the importance of AKI should be considered as an urgent issue in the management of COVID-19.